CEL-SCI is a biotechnology company. It is involved in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. The company provides Multikine, an investigational immunotherapy for treating head and neck cancer, and L.E.A.P.S. (ligand epitope antigen presentation system), a peptide epitope delivery technology for treating rheumatoid arthritis.